Dr. De Bruycker Aurélie, Radiotherapie - Oncologie
1001.299.623 · rovalta.com · 28/09/2026
Dr. De Bruycker Aurélie, Radiotherapie - Oncologie
Financial year 2024 · Closed on 31/12/2024
Overview
Identity
Source · BCE/KBODr. De Bruycker Aurélie, Radiotherapie - Oncologie is a Private limited company incorporated in 2023. Its registered office is in Lochristi.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 1001.299.623
- Incorporation
- 17/10/2023
- Legal form
- Private limited company
- Registered office
- Pauwstraat 32
9080 Lochristi · FlandreSee on map - Contributed capital
- 2 500,00 €
- Latest accounts
- 31/12/2024
Financials
Source · NBB, 1 filingTrend over 1 financial year
| 2024 | |
|---|---|
| Income statement | |
| Gross margin | 88,9 k € |
| EBITDA | 88,4 k € |
| Operating result | 88,4 k € |
| Net result | 69,6 k € |
| Balance sheet | |
| Equity | 72,1 k € |
| Total assets | 81 k € |
| Cash | 64,4 k € |
| Debts | 8,9 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20241 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
AURELIE DE BRUYCKER | Director |
Financials
Full financial information
Source · NBB| 2024 | |
|---|---|
| Type of account | Micro model |
| Start of the financial year | 12/10/2023 |
| Closing of the financial year | 31/12/2024 |
| Length of the financial year | 15 months |
| Filing date | 25/07/2025 |
| General meeting | 27/06/2025 |
| Currency of the financial year | EUR |
| NBB quality label | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 1 filing| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2024 | 27/06/2025 | 25/07/2025 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20241 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
AURELIE DE BRUYCKER | Director |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other19/10/2023RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Pauwstraat 32, 9080 LochristiCurrent | accounts 2024 | Accounts 2024 · 2025-00312545 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Dr. De Bruycker Aurélie, Radiotherapie - OncologieCurrent | CBE | |
| DE BRUYCKER AURELIE | accounts 2024 | Accounts 2024 · 2025-00312545 |
Events
- 2024Annual accounts 202469,6 k €
- 17/10/2023IncorporationPrivate limited company